Ramsay Générale de Santé — one of the largest private hospital groups in France — may soon enter a new phase in its ownership structure and strategic positioning. Its majority shareholder, Ramsay Health Care, is considering divesting its stake, a move that could reshape the private healthcare sector in France.
Analysis and insights by the experts at AURIS Finance, a corporate finance and M&A advisory firm.
Alongside Elsan, Ramsay Santé is a leader in the French private clinic market. Listed in Paris, Ramsay France is currently owned 52.8% by Ramsay Health Care (RHC) and 40% by Crédit Agricole Assurances, a long-term French shareholder that has stated it does not intend either to increase its stake or to sell its shares.
This situation has created a strategic impasse for the Australian group, which now aims to exit its investment. To achieve this, RHC has proposed distributing its stake in Ramsay Santé directly to its own shareholders through a structure approved by its board of directors. The plan remains subject to a shareholder vote expected at the end of 2026.
More information about Ramsay Santé
Regulatory Pressure
For Ramsay Health Care, reducing its exposure in Europe has become a key strategic priority, as the group seeks to refocus on its historical markets in Australia and the United Kingdom.
Within Europe, France has proven particularly challenging due to its complex regulatory framework. In 2022, the American investment fund KKR withdrew its €14 billion friendly takeover offer for Ramsay Health Care. At the time, KKR already held around 42% of Elsan.
Had KKR taken control of Ramsay Santé — the second-largest private healthcare operator in France — it would likely have faced strong opposition from French and European competition authorities due to the risk of market dominance.
The French Healthcare Exception
France’s healthcare market presents unique structural challenges. Pricing pressures, strict regulatory oversight, and strong government involvement in controlling healthcare spending all limit growth opportunities for private operators.
These constraints make a straightforward divestment scenario more complex for Ramsay Health Care, which is now actively exploring ways to exit its French operations.
Strong Market Fundamentals
Despite the Australian group’s desire to withdraw, other investors could show strong interest in acquiring the business.
Across France — and more broadly in Europe — demographic trends remain favorable for healthcare providers. Aging populations, the increasing prevalence of chronic diseases, and rising demand for rehabilitation, follow-up care, and oncology services are creating significant growth opportunities for private healthcare operators.
Ramsay Santé is positioned across the entire healthcare value chain, operating around 465 clinics and medical centers across five European countries.
The group treats nearly 12 million patients every year and generates approximately €5.2 billion in annual revenue, making it one of the largest private healthcare providers in Europe.
A Sector in Consolidation
In recent months, several consolidation and acquisition transactions have taken place within the French private healthcare market, often combining industrial strategies with real estate investment structures.
In summer 2023, Elsan formed a partnership with La Française Real Estate Managers. As part of this agreement, Elsan sold a portfolio of five healthcare facilities for €120 million, establishing a long-term partnership aimed at modernizing infrastructure and financing the energy transition of these facilities.
Our Experts by Your Side
Investment funds — particularly specialized healthcare and real estate investors — are increasingly attracted to healthcare assets. The potential independence of Ramsay Santé could open the door to significant sector reshaping, acquisitions, and divestments.
At AURIS Finance, our sector-specialized advisors support healthcare companies across France and Europe in their M&A transactions, financing strategies, and capital structure decisions, helping drive long-term growth.
